PRTK Annual CFO
-$66.14 M
-$17.87 M-37.01%
31 December 2022
Summary:
As of January 21, 2025, PRTK annual cash flow from operations is -$66.14 million, with the most recent change of -$17.87 million (-37.01%) on December 31, 2022. During the last 3 years, it has risen by +$67.90 million (+50.66%).PRTK Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Quarterly CFO
-$1.78 M
-$12.87 M-116.01%
30 June 2023
Summary:
As of January 21, 2025, PRTK quarterly cash flow from operations is -$1.78 million, with the most recent change of -$12.87 million (-116.01%) on June 30, 2023. Over the past year, it has increased by +$12.72 million (+87.75%).PRTK Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK TTM CFO
-$23.22 M
+$12.72 M+35.40%
30 June 2023
Summary:
As of January 21, 2025, PRTK TTM cash flow from operations is -$23.22 million, with the most recent change of +$12.72 million (+35.40%) on June 30, 2023. Over the past year, it has increased by +$3.94 million (+14.51%).PRTK TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -37.0% | +87.8% | +14.5% |
| 3 y3 years | +50.7% | +91.3% | +79.7% |
| 5 y5 years | +15.8% | +92.2% | +82.7% |
PRTK Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -524.0% | -103.9% | -179.3% |
Paratek Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$1.78 M(-116.0%) | -$23.22 M(-35.4%) |
| Mar 2023 | - | $11.09 M(-155.1%) | -$35.94 M(-45.7%) |
| Dec 2022 | -$66.14 M(+37.0%) | -$20.11 M(+62.0%) | -$66.14 M(+0.5%) |
| Sept 2022 | - | -$12.42 M(-14.3%) | -$65.84 M(+142.4%) |
| June 2022 | - | -$14.50 M(-24.1%) | -$27.16 M(-40.8%) |
| Mar 2022 | - | -$19.11 M(-3.5%) | -$45.87 M(-5.0%) |
| Dec 2021 | -$48.27 M(-53.3%) | -$19.81 M(-175.4%) | -$48.27 M(-7.7%) |
| Sept 2021 | - | $26.26 M(-179.1%) | -$52.31 M(-51.3%) |
| June 2021 | - | -$33.21 M(+54.3%) | -$107.49 M(+13.6%) |
| Mar 2021 | - | -$21.52 M(-9.8%) | -$94.62 M(-8.5%) |
| Dec 2020 | -$103.42 M(-22.8%) | -$23.85 M(-17.5%) | -$103.42 M(-10.1%) |
| Sept 2020 | - | -$28.92 M(+42.3%) | -$115.10 M(+0.7%) |
| June 2020 | - | -$20.33 M(-33.0%) | -$114.35 M(-11.1%) |
| Mar 2020 | - | -$30.33 M(-14.6%) | -$128.62 M(-4.1%) |
| Dec 2019 | -$134.04 M(+65.1%) | -$35.53 M(+26.1%) | -$134.04 M(+14.1%) |
| Sept 2019 | - | -$28.16 M(-18.6%) | -$117.50 M(+7.0%) |
| June 2019 | - | -$34.59 M(-3.2%) | -$109.80 M(+12.2%) |
| Mar 2019 | - | -$35.76 M(+88.3%) | -$97.88 M(+20.6%) |
| Dec 2018 | -$81.18 M(+3.3%) | -$18.98 M(-7.2%) | -$81.18 M(-4.0%) |
| Sept 2018 | - | -$20.47 M(-9.7%) | -$84.58 M(+6.2%) |
| June 2018 | - | -$22.68 M(+19.0%) | -$79.61 M(+9.5%) |
| Mar 2018 | - | -$19.05 M(-14.9%) | -$72.70 M(-7.5%) |
| Dec 2017 | -$78.57 M(-16.5%) | -$22.39 M(+44.4%) | -$78.57 M(-2.3%) |
| Sept 2017 | - | -$15.50 M(-1.6%) | -$80.42 M(-14.4%) |
| June 2017 | - | -$15.76 M(-36.8%) | -$93.97 M(-6.5%) |
| Mar 2017 | - | -$24.93 M(+2.9%) | -$100.52 M(+6.8%) |
| Dec 2016 | -$94.10 M(+72.1%) | -$24.23 M(-16.6%) | -$94.10 M(+10.0%) |
| Sept 2016 | - | -$29.05 M(+30.2%) | -$85.56 M(+9.3%) |
| June 2016 | - | -$22.30 M(+20.5%) | -$78.28 M(+12.0%) |
| Mar 2016 | - | -$18.51 M(+18.0%) | -$69.88 M(+27.8%) |
| Dec 2015 | -$54.68 M(+195.1%) | -$15.69 M(-27.9%) | -$54.68 M(+3.3%) |
| Sept 2015 | - | -$21.77 M(+56.5%) | -$52.93 M(+55.8%) |
| June 2015 | - | -$13.91 M(+320.6%) | -$33.97 M(+56.5%) |
| Mar 2015 | - | -$3.31 M(-76.3%) | -$21.71 M(+17.1%) |
| Dec 2014 | -$18.53 M | -$13.94 M(+395.1%) | -$18.53 M(+84.3%) |
| Sept 2014 | - | -$2.81 M(+70.6%) | -$10.06 M(+11.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2014 | - | -$1.65 M(+1159.5%) | -$9.05 M(-15.3%) |
| Mar 2014 | - | -$131.00 K(-97.6%) | -$10.68 M(-27.9%) |
| Dec 2013 | -$14.82 M(-2.6%) | -$5.46 M(+202.2%) | -$14.82 M(-35.2%) |
| Sept 2013 | - | -$1.81 M(-44.9%) | -$22.88 M(+57.0%) |
| June 2013 | - | -$3.28 M(-23.2%) | -$14.57 M(-8.5%) |
| Mar 2013 | - | -$4.27 M(-68.4%) | -$15.93 M(+4.8%) |
| Dec 2012 | -$15.21 M(+166.4%) | -$13.53 M(-308.1%) | -$15.21 M(-364.3%) |
| Sept 2012 | - | $6.50 M(-240.3%) | $5.75 M(-194.9%) |
| June 2012 | - | -$4.63 M(+30.6%) | -$6.06 M(+22.1%) |
| Mar 2012 | - | -$3.55 M(-147.7%) | -$4.96 M(-13.1%) |
| Dec 2011 | -$5.71 M(-70.8%) | $7.43 M(-239.9%) | -$5.71 M(-70.0%) |
| Sept 2011 | - | -$5.31 M(+50.2%) | -$19.02 M(+5.1%) |
| June 2011 | - | -$3.54 M(-17.6%) | -$18.10 M(-2.0%) |
| Mar 2011 | - | -$4.29 M(-27.0%) | -$18.47 M(-5.5%) |
| Dec 2010 | -$19.55 M(-2455.2%) | -$5.88 M(+33.9%) | -$19.55 M(+12.8%) |
| Sept 2010 | - | -$4.39 M(+12.3%) | -$17.32 M(-355.1%) |
| June 2010 | - | -$3.91 M(-27.2%) | $6.79 M(+95.1%) |
| Mar 2010 | - | -$5.37 M(+46.7%) | $3.48 M(+319.4%) |
| Dec 2009 | $830.00 K(-104.1%) | -$3.66 M(-118.5%) | $830.00 K(-107.8%) |
| Sept 2009 | - | $19.73 M(-373.2%) | -$10.65 M(-64.7%) |
| June 2009 | - | -$7.22 M(-10.0%) | -$30.13 M(-1.8%) |
| Mar 2009 | - | -$8.02 M(-47.0%) | -$30.70 M(+52.5%) |
| Dec 2008 | -$20.13 M(-229.1%) | -$15.14 M(-6328.8%) | -$20.13 M(+22.7%) |
| Sept 2008 | - | $243.00 K(-103.1%) | -$16.41 M(-156.1%) |
| June 2008 | - | -$7.79 M(-405.5%) | $29.27 M(+12.8%) |
| Mar 2008 | - | $2.55 M(-122.3%) | $25.94 M(+66.3%) |
| Dec 2007 | $15.60 M(-160.2%) | -$11.42 M(-124.9%) | $15.60 M(-24.0%) |
| Sept 2007 | - | $45.93 M(-513.2%) | $20.52 M(-165.5%) |
| June 2007 | - | -$11.12 M(+42.6%) | -$31.32 M(+18.9%) |
| Mar 2007 | - | -$7.79 M(+20.0%) | -$26.34 M(+1.7%) |
| Dec 2006 | -$25.91 M(+20.6%) | -$6.50 M(+9.8%) | -$25.91 M(+33.5%) |
| Sept 2006 | - | -$5.91 M(-3.6%) | -$19.41 M(+43.8%) |
| June 2006 | - | -$6.13 M(-16.7%) | -$13.50 M(+83.3%) |
| Mar 2006 | - | -$7.37 M | -$7.37 M |
| Dec 2005 | -$21.48 M(+25.7%) | - | - |
| Dec 2004 | -$17.09 M | - | - |
FAQ
- What is Paratek Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals annual CFO year-on-year change?
- What is Paratek Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals quarterly CFO year-on-year change?
- What is Paratek Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals TTM CFO year-on-year change?
What is Paratek Pharmaceuticals annual cash flow from operations?
The current annual CFO of PRTK is -$66.14 M
What is the all time high annual CFO for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high annual cash flow from operations is $15.60 M
What is Paratek Pharmaceuticals annual CFO year-on-year change?
Over the past year, PRTK annual cash flow from operations has changed by -$17.87 M (-37.01%)
What is Paratek Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of PRTK is -$1.78 M
What is the all time high quarterly CFO for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high quarterly cash flow from operations is $45.93 M
What is Paratek Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, PRTK quarterly cash flow from operations has changed by +$12.72 M (+87.75%)
What is Paratek Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of PRTK is -$23.22 M
What is the all time high TTM CFO for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high TTM cash flow from operations is $29.27 M
What is Paratek Pharmaceuticals TTM CFO year-on-year change?
Over the past year, PRTK TTM cash flow from operations has changed by +$3.94 M (+14.51%)